Global Validation Regulations & Standards

Training Programs That Teach WHO, ISPE and PDA Validation Expectations

Training Programs That Teach WHO, ISPE and PDA Validation Expectations Introduction to Validation Expectations in Pharma In the pharmaceutical industry, validation is a critical component ensuring the quality and safety of products. Regulatory bodies such as the WHO, ISPE, and PDA provide comprehensive guidance that informs best practices during the validation process. This article aims to serve as a step-by-step…

Continue Reading Training Programs That Teach WHO, ISPE and PDA Validation Expectations

Building a Validation Library: WHO, ISPE and PDA Documents Every QA Lead Should Know

Building a Validation Library: Essential Documents Every QA Lead Should Know In the pharmaceutical industry, maintaining rigorous validation standards is critical in ensuring that products are safe, effective, and produced in compliance with applicable regulatory requirements. Regulatory agencies such as the US FDA, EMA, and others have established extensive guidelines pertaining to process validation, which necessitate a robust approach to…

Continue Reading Building a Validation Library: WHO, ISPE and PDA Documents Every QA Lead Should Know

WHO Vaccine Guidance: Validation Requirements for Fill-Finish and Cold Chain

WHO Vaccine Guidance: Validation Requirements for Fill-Finish and Cold Chain WHO Vaccine Guidance: Validation Requirements for Fill-Finish and Cold Chain The validation of pharmaceutical processes, particularly in the context of WHO vaccines, is critical to ensuring that products are safe, effective, and of high quality. This article delves into the regulatory expectations surrounding validation as documented in guidance from the…

Continue Reading WHO Vaccine Guidance: Validation Requirements for Fill-Finish and Cold Chain

Industry Guidance for Cleaning Validation: How PDA and ISPE Support Annex 15

Integrating PDA and ISPE Positions into Cleaning Validation Programs Cleaning validation is a crucial aspect of pharmaceutical manufacturing, ensuring the removal of residues from previous products and cleaning agents to prevent cross-contamination and ensure product safety. Regulatory bodies such as the US FDA, EMA, and PIC/S provide frameworks and guidance to govern validation processes. This document serves as a comprehensive…

Continue Reading Industry Guidance for Cleaning Validation: How PDA and ISPE Support Annex 15

Cost-Effective Cleanroom Monitoring Programs for ISO 14644 Compliance

Cost-Effective Cleanroom Monitoring Programs for ISO 14644 Compliance Cost-Effective Cleanroom Monitoring Programs for ISO 14644 Compliance In the pharmaceutical industry, compliance with FDA, EMA, and other regulatory requirements is paramount for ensuring product safety and efficacy. A critical element of this compliance is the establishment of effective cleanroom monitoring programs that align with ISO 14644 standards. This article serves as…

Continue Reading Cost-Effective Cleanroom Monitoring Programs for ISO 14644 Compliance

Cleanroom Monitoring for Aseptic Processing Lines and Critical Grade A Zones

Cleanroom Monitoring for Aseptic Processing Lines and Critical Grade A Zones In the pharmaceutical industry, maintaining the integrity of aseptic processing areas is critical for ensuring product safety and efficacy. Regulatory agencies such as the US FDA, EMA, MHRA, and PIC/S establish stringent guidelines for monitoring cleanrooms, particularly in Grade A zones where direct product contact occurs. This article provides…

Continue Reading Cleanroom Monitoring for Aseptic Processing Lines and Critical Grade A Zones

ISO 14644 Considerations for Single-Use and Modular Cleanroom Technologies

ISO 14644 Considerations for Single-Use and Modular Cleanroom Technologies The pharmaceutical industry continually adapts to emerging technologies and methodologies, driving the need for validation strategies that accommodate novel cleanroom concepts. Among these, single-use cleanrooms, modular systems, and flexible facilities are gaining ground, demanding a comprehensive understanding of regulatory expectations under ISO 14644 standards and their intersection with good manufacturing practices…

Continue Reading ISO 14644 Considerations for Single-Use and Modular Cleanroom Technologies

Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching

Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching In the pharmaceutical industry, regulations surrounding computerized systems and electronic records are increasingly stringent. Both Annex 11 of the EU Good Manufacturing Practice (GMP) guidelines and 21 CFR Part 11 of the US FDA regulation emphasize the importance of compliance…

Continue Reading Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching

Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems

Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems The digital transformation of the pharmaceutical industry necessitates a robust framework for electronic archiving and data retention. Compliance with FDA, EMA, and other regulatory authorities regarding electronic records demands a thorough understanding of the embedded requirements…

Continue Reading Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems

Contract Manufacturer Process Validation: Sponsor Oversight and FDA Expectations

Contract Manufacturer Process Validation: Sponsor Oversight and FDA Expectations Contract Manufacturer Process Validation: Sponsor Oversight and FDA Expectations In the modern pharmaceutical landscape, companies frequently collaborate with Contract Manufacturing Organizations (CMOs) to leverage their manufacturing capabilities while meeting regulatory expectations. The complexity of ensuring compliance with both the FDA and EMA frameworks can be daunting. This article will outline a…

Continue Reading Contract Manufacturer Process Validation: Sponsor Oversight and FDA Expectations